SecBot SecBot
EFFECT ·Filed May 22, 2026

PEPG

PepGen Inc.
BEARISH
Impact 7/10
Horizonweeks Processed5mo ago SEC9999999995-26-001734
IPO/offering going effective
Actionable Insight ▼ Bearish

The effective shelf creates immediate dilution risk. Monitor for ATM takedowns and any pricing announcements. The unresolved clinical hold adds binary risk, positive resolution could offset some dilution concerns, but the capital raise signal is clear. Consider positioning for continued weakness until the company provides clarity on clinical hold resolution and capital deployment plans.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$1.51
T+0 close · May 22, 2026 · via day close
Latest settled
+92.72%
T+60 · $2.91
Vs SPY
+89.53%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 22 $1.51entry
  2. T+1 · 6mo ago +1.32%α +0.74% · $1.53
  3. T+5 · 6mo ago −2.65%α −4.31% · $1.47
  4. T+20 · 5mo ago +25.83%α +27.24% · $1.90
  5. T+60 · 3mo ago +92.72%α +89.53% · $2.91

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

PepGen's S-3 shelf registration (File No. 333-296016) became effective on May 21, 2026, enabling the company to sell up to $400M in securities including a $100M ATM facility. This follows a prior S-3 filing 3 days earlier and comes amid an unresolved FDA partial clinical hold on its lead DM1 candidate, with Q1 2026 cash of $132.3M sufficient into 2H 2027. The effectiveness creates immediate dilution overhang for existing shareholders.

Key Facts

  • S-3 shelf registration became effective on May 21, 2026
  • Shelf covers up to $400M in securities including a $100M ATM facility
  • Prior S-3 filed May 19, 2026 replaced an ATM with $88.5M remaining capacity
  • Q1 2026 net loss of $17.8M; cash of $132.3M sufficient into 2H 2027
  • Unresolved FDA partial clinical hold on lead DM1 candidate
  • Massive increase in authorized ATM capacity signals expected need for significant additional capital

Financial Impact

Up to $400M in potential dilution from shelf securities, with $100M ATM facility representing ~93% of current $107M market cap

dilutionshare countcash runway

Risk Factors

  • Immediate dilution overhang from $100M ATM facility
  • Unresolved FDA partial clinical hold on lead DM1 candidate
  • Cash runway only into 2H 2027 without additional capital

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001734
Document: 9999999995-26-001734-index.html9999999995-26-001734
Document: 9999999995-26-001734.txt9999999995-26-001734

Track record

12 reports on PEPG

Performance horizon

5 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +31.95% at T+20 after the Aug 6, 2026 report. 5 of 6 went positive at some point.

Filters
  1. Nov 12, 20264d ago 8-K Bearish 6/10 Entry $4.36 to $4.19 Now $4.19 +3.90% ▲ +3.90% +1.99% vs SPY
  2. Nov 12, 20264d ago 424B5 Bearish 6/10 Entry $4.36 to $4.19 Now $4.19 +3.90% ▲ +3.90% +1.99% vs SPY
  3. Nov 10, 20266d ago 424B5 Bearish 6/10 Entry $5.26 to $5.04 Now $4.19 +20.34% ▲ +4.18% +3.83% vs SPY
  4. Nov 10, 20266d ago 8-K Bullish 7/10 Entry $4.61 to $5.26 Now $4.19 −9.11% ▲ +14.10% +12.78% vs SPY
  5. Aug 6, 202614w ago 8-K Bullish 7/10 Entry $2.41 to $2.85 Now $4.19 +73.86% ▲ +18.26% +17.65% vs SPY
  6. Jun 11, 202622w ago Institutional Cluster Neutral 2/10 Entry $1.51 to $1.47 Now $4.19 +177.48% ▼ −2.65% −3.19% vs SPY
  7. Jun 11, 202622w ago Institutional Cluster Neutral 3/10 Entry $1.51 to $1.47 Now $4.19 +177.48% ▼ −2.65% −3.19% vs SPY
  8. May 22, 202625w ago EFFECT Bearish 7/10 Viewing Entry $1.51 to $1.53 Now $4.19 −177.48% ▼ −1.32% −0.74% vs SPY
  9. May 19, 202625w ago S-3 Bearish 7/10 Entry $1.38 to $1.44 Now $4.19 −203.62% ▼ −4.35% −3.31% vs SPY
  10. May 12, 202626w ago 8-K Neutral 5/10 Entry $1.78 to $1.78 Now $4.19 +135.39% · 0.00% +0.00% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens in 6h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 22, 2026